Mioconsult

MIOCONSULT provides expert IFRS advisory services to biotech and pharmaceutical companies, specialising in revenue recognition (IFRS 15) for licensing deals and business combinations. Our Expertise:* Revenue recognition for biotech and pharmaceutical licensing transactions * IFRS 15 implementation and compliance for complex deals * Advisory on milestone payments, royalties, and variable consideration * In-licensing deal accounting covering asset classification (IAS 38), business combinations (IFRS 3), joint arrangements (IFRS 11), and investment accounting (IAS 27/28)* Equity transfer accounting in alliance deals from a consolidation perspective * Business combination accounting guidance * Training and workshops for finance teams Industry Focus: Biotechnology, pharmaceuticals, and medical technology companies requiring specialist accounting guidance for licensing arrangements, alliance deals, complex revenue streams, and equity-linked transactions. Founded by Michelle Olufeso Nwokobia: Former Head of Accounting & External Relations at Roche and co-developer of IFRS 15 through the IASB/FASB process, bringing over 12 years of hands-on experience with €10M+ licensing deals and complex alliance structures. Contact: info@mioconsult.com |+49 1522 6001338